Efficacy of Mogamulizumab by Prior Systemic Therapy in Patients With Previously Treated Cutaneous T-Cell Lymphoma: Post Hoc Analysis From the Phase 3 MAVORIC Study

被引：0
|
作者：
Scarisbrick, J. [1 ]
Zinzani, P. L. [2 ]
Horwitz, S. [3 ]
Kim, Y. H. [4 ]
Moskowitz, A. J. [3 ]
Porcu, P. [5 ]
Leoni, M. [6 ]
Dwyer, K. [6 ]
Sun, W. [6 ]
Nikonova, E. [7 ]
Bagot, M. [8 ]
机构：
[1] Univ Hosp Birmingham, Birmingham, W Midlands, England
[2] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[6] Kyowa Kirin Pharmaceut Dev Inc, Princeton, NJ USA
[7] Kyowa Kirin Inc, Bedminster, NJ USA
[8] Univ Paris 07, Inserm U976, Hop St Louis, AP HP, Paris, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷
关键词：
Cutaneous T-cell Lymphoma; Mogamulizumab; Mycosis Fungoides; Sezary syndrome;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH19-PO-0
引用
收藏
页码：94 / 94
页数：1
相关论文
共 43 条
  • [31] IMPACT OF NON-CTCL DERMATOLOGICAL DIAGNOSES AND ADJUVANT THERAPIES ON CUTANEOUS T-CELL LYMPHOMA PATIENTS TREATED WITH TOTAL SKIN ELECTRON-BEAM RADIATION-THERAPY
    WILSON, LD
    COOPER, DL
    GOODRICH, AL
    FRIEDMAN, ND
    FELDMAN, AM
    BRAVERMAN, IM
    KACINSKI, BM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04): : 829 - 837
  • [32] Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study
    Dummer, Reinhard
    Prince, Henry M.
    Whittaker, Sean
    Horwitz, Steven M.
    Kim, Youn H.
    Scarisbrick, Julia
    Quaglino, Pietro
    Zinzani, Pier Luigi
    Wolter, Pascal
    Eradat, Herbert
    Pinter-Brown, Lauren
    Sanches, Jose A.
    Ortiz-Romero, Pablo L.
    Akilov, Oleg E.
    Geskin, Larisa
    Huen, Auris
    Walewski, Jan
    Wang, Yinghui
    Lisano, Julie
    Richhariya, Akshara
    Feliciano, Joseph
    Zhu, Yanyan
    Bunn, Veronica
    Little, Meredith
    Zagadailov, Erin
    Dalal, Mehul R.
    Duvic, Madeleine
    EUROPEAN JOURNAL OF CANCER, 2020, 133 : 120 - 130
  • [33] Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene
    Cabello, Irene
    Alia, Pedro
    Pinto, Xavier
    Muniesa, Cristina
    Fernandez-de-Misa, Ricardo
    Penate, Yerai
    Morillo, Mercedes
    Perez-Farriols, Amparo
    Estrach, Teresa
    Izu, Rosa
    Gallardo, Fernando
    Roman, Concepcion
    Cervigon, Ivan
    Ortiz-Brugues, Ariadna
    Ortiz-Romero, Pablo L.
    Servitje, Octavio
    JAMA DERMATOLOGY, 2018, 154 (12) : 1424 - 1431
  • [34] A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs
    Bagot, Martine
    Hasan, Baktiar
    Whittaker, Sean
    Beylot-Barry, Marie
    Knobler, Robert
    Shah, Emad
    Marreaud, Sandrine
    Morris, Stephen
    Dalle, Stephane
    Servitje, Octavio
    Cowan, Richard
    Vakeva, Liisa
    Chaby, Guillaume
    Jonak, Constanze
    Fox, Christopher P.
    Ritchie, Diana
    Vermeer, Maarten H.
    Stadler, Rudolf
    Ortiz Romero, Pablo L.
    Scarisbrick, Julia
    Quaglino, Pietro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (03) : 286 - 294
  • [35] Low-Dose (10-Gy) Total Skin Electron Beam Therapy for Cutaneous T-Cell Lymphoma: An Open Clinical Study and Pooled Data Analysis
    Kamstrup, Maria R.
    Gniadecki, Robert
    Iversen, Lars
    Skov, Lone
    Petersen, Peter Meidahl
    Loft, Annika
    Specht, Lena
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 138 - 143
  • [36] Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019
    Girardi, Michael
    Carlson, Kacie
    Huang, Xingyue
    Corman, Shelby L.
    Edmundson, Patrick
    Schmier, Jordana
    Kale, Hrishikesh P.
    Raina, Rutika
    Foss, Francine
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [37] Long term survival, time to next treatment and CD30 expression in patients with advanced CD30+ cutaneous T-cell lymphoma treated with Brentuximab vedotin - A monocentric retrospective analysis of twelve patients
    Gosmann, Janika
    Stadler, Rudolf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (04): : 514 - 517
  • [38] Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study
    Kamstrup, M. R.
    Lindahl, L. M.
    Gniadecki, R.
    Iversen, L.
    Skov, L.
    Petersen, P. M.
    Loft, A.
    Specht, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) : 399 - 404
  • [39] Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study
    Christensen, Eidi
    Foss, Olav Andreas
    Holien, Toril
    Juzenas, Petras
    Peng, Qian
    PHARMACEUTICS, 2024, 16 (06)
  • [40] A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs
    Martine Bagot
    Baktiar Hasan
    Sean Whittaker
    Marie Beylot-Barry
    Robert Knobler
    Emad Shah
    Sandrine Marreaud
    Stephen Morris
    Stephane Dalle
    Octavio Servitje
    Richard Cowan
    Liisa Väkevä
    Guillaume Chaby
    Constanze Jonak
    Christopher P Fox
    Diana Ritchie
    Maarten H Vermeer
    Rudolf Stadler
    Pablo L Ortiz Romero
    Julia Scarisbrick
    Pietro Quaglino
    European Journal of Dermatology, 2017, 27 : 286 - 294
12345